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Abstract Using cell surface biotinylation and Western blotting,
we investigated the extent to which native P2X1 receptors in rat
vas deferens are internalised after exposure to agonist. Exposure
to 100 WM K,L-meATP 30 min prior and during a 10 min
biotinylation period resulted in a V50% reduction in the amount
of biotinylated P2X1 receptor indicating that activation of the
receptor by agonist induces receptor internalisation. Further-
more, biotinylation under saturating conditions suggests that
once internalised, a rapid recycling of P2X1 receptor back to the
cell surface occurs. The physiological implications of these
mechanisms in terms of receptor function are discussed. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
P2X receptors are membrane cation channels gated by the
binding of extracellular ATP. Seven distinct mammalian iso-
forms of the receptor (P2X1ÿ7) have been cloned each with
di¡erent biophysical and pharmacological properties [1]. Dif-
ferences in native P2X receptor responses result not only from
the di¡erential expression of di¡erent P2X isoforms but also
from the formation of heteromultimers between di¡erent iso-
forms [2] and possibly through the existence of alternatively
spliced isoforms [3].
The characteristic features of P2X-mediated responses in
smooth muscle cells are a high sensitivity to K,L methylene
ATP (K,L-meATP, EC50V1 WM) and a rapid desensitisation
of the response during the continued presence of agonist. This
corresponds closely to the phenotype of recombinant homo-
meric P2X1 receptors [4,5] and studies on P2X1 knockout
mice have shown that the P2X1 receptor is essential for
P2X-mediated responses in vas deferens [6]. The underlying
mechanism of desensitisation of the P2X1 receptor is unclear
and could possibly involve receptor internalisation. Agonist-
stimulated internalisation is a common mechanism for G pro-
tein-coupled receptors [7]. However, the extent to which in-
ternalisation plays a role in the regulation of ligand-gated ion
channels is unclear. Examples of ligand-gated ion channels
that undergo receptor internalisation include the GABAA
and AMPA receptors [8,9]. Recent studies using over-ex-
pressed P2X1 receptor^green £uorescent protein (GFP) chime-
ras have shown that 80^90% of the £uorescence can be in-
ternalised following agonist stimulation [10,11]. Therefore, by
inference a component of receptor recovery from desensitisa-
tion is dependent on the recycling of the receptors back to the
surface. However, whether P2X1 receptor internalisation oc-
curs in native tissue with physiological levels of receptor and if
this plays a role in the tachyphalaxis of P2X1 receptor re-
sponses remains to be determined. In order to address these
questions we have used cell surface biotinylation to measure
the membrane localisation of P2X1 receptors [4] to estimate
the extent of agonist-induced receptor internalisation in the
vas deferens and to compare this to the recovery of P2X
receptor-mediated contractile responses following agonist
stimulation.
2. Materials and methods
2.1. Surface protein biotinylation
Male Wistar rats (250^300 g) were killed by cervical dislocation.
Vasa deferentia were cut into four, washed in phosphate-bu¡ered sa-
line (PBS) and placed in 940 Wl of PBS in 24 well culture dishes (two
vas deferens segments per well). Biotinylating agent (EZ-Link1 Sulfo-
NHS-LC-Biotin (Pierce, USA)) was added in a 50 Wl volume to give
the appropriate ¢nal concentration (see ¢gure legends). After biotiny-
lation tissues were washed extensively in PBS and placed in 550 Wl of
homogenisation bu¡er [4] on ice. For agonist studies K,L-meATP
(Sigma, UK) was applied 30 min before addition of biotinylating
agent in a 10 Wl volume to give a ¢nal concentration of 100 WM.
Incubations and washes were conducted at room temperature. Tissues
were homogenised with a Polytron homogeniser and centrifuged at
16 000Ug (4‡C) for 2 min. A 5 Wl aliquot of the supernatant was
assayed for total protein content using Bradford reagent and the
remaining supernatant diluted to 5 mg/ml in bu¡er H. For quanti¢-
cation of total P2X1 receptor (biotinylated and non-biotinylated), a
30 Wl aliquot was mixed with an equal volume of gel loading bu¡er.
For isolation of biotinylated proteins, 30 Wl of streptavidin agarose
beads (Sigma) were added to 400 Wl of supernatant and mixed on a
rolling shaker at 4‡C for 3 h. Beads were washed twice in homoge-
nisation bu¡er, three times in PBS and 30 Wl of gel sample bu¡er
added.
2.2. Gel electrophoresis and quanti¢cation
Protein samples (20 Wg/well) were heated to 80‡C for 5 min before
separation on a 10% SDS^PAGE gel. The gel was transferred to
Hybond-P membrane (Amersham, UK) and processed for antibody
staining (anti-P2X1 (Alamone, Israel) 1:1000 or extracellular signal-
regulated kinase (ERK) (Santa Cruz, CA, USA) 1:500 dilution) as
described elsewhere [4]. Protein bands were visualised using an ECL
(Plus) kit and with Hyper¢lm MP (Amersham). Images were captured
using a Bio-Rad GS-670 densitometer and protein bands quanti¢ed
using the NIH Image computer.
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2.3. Organ bath analysis of contractile responses in rat vas deferens
Vas deferens contractions were measured as described previously
[6]. Agonist (K,L-meATP, 10 WM ¢nal concentration) was added to
the organ bath at 30 or 10 min intervals and removed by three washes.
3. Results
Sulfo-NHS-LC-Biotin can be used to label primary amines
of surface proteins [12] and has been used to characterise
surface expression of recombinant P2X receptors [4,13]. In
this study, we have used this technique in combination with
streptavidin agarose bead precipitation and Western blot
analysis with an anti-P2X1 antibody to study surface P2X1
receptor levels in the rat vas deferens. A single protein band
of V60 kDa corresponding to the glycosylated form of the
P2X1 receptor [14,15] was detected by the P2X1 antibody
(Figs. 1, 3 and 4). Biotinylation of membrane-localised P2X1
receptors was time and concentration dependent and satu-
rated at 500 Wg/ml Sulfo-NHS-LC-Biotin following 10 min
biotinylation (Figs. 1 and 3). In order to rule out the possi-
bility that cellular damage from dissection could allow bio-
tinylation of intracellular proteins, we assayed the exclusively
cytoplasmic protein ERK. Two ERK isoforms were detected
from total protein samples, however, biotinylated forms were
not detected (Fig. 2). This con¢rms that the technique is se-
lective for extracellular proteins and we can therefore use the
level of biotinylation as a measure of surface localisation to
determine whether activation of the receptor results in subse-
quent internalisation of native P2X1 receptors.
In order to investigate the extent of receptor internalisation
we quanti¢ed the levels of biotinylated P2X1 receptors under
control conditions and following agonist stimulation (30 min
prestimulation and during biotinylation). In initial studies at a
saturating concentration of Sulfo-NHS-LC-Biotin (500 Wg/ml)
there was no di¡erence between the levels of biotinylated
P2X1 receptors following 30 min biotinylation (agonist treat-
ment 97.1 þ 2.5% of non-treated controls, n = 4 experiments).
The biotinylation technique does not give a snapshot measure
of surface localisation at any one time but an estimate of the
number of receptors that have been at the surface during the
Fig. 1. Biotinylation of rat vas deferens P2X1 receptors with Sulfo-
NHS-LC-Biotin is concentration dependent. A: Puri¢ed biotinylated
P2X1 (inset shows total P2X1). B: Optical density of the biotinyl-
ated P2X1 protein bands in A plotted against concentration of bio-
tinylating agent (10 min incubation). Lane markers correspond to
the concentration of Sulfo-NHS-LC-Biotin in Wg/ml. Size markers
are in kDa.
Fig. 2. The cytoplasmic protein ERK is not biotinylated. Rat vasa
deferentia were exposed to Sulfo-NHS-LC-Biotin (500 Wg/ml) for
10 min. Figure shows a representative (n = 4) Western blot probed
with anti-ERK antibody which detects the cytoplasmic proteins
ERK1 (44 kDa) and ERK2 (42 kDa). Lane 1, total protein sample.
Lane 2, puri¢ed biotinylated proteins. Molecular weight markers in
kDa.
Fig. 3. E¡ect of agonist stimulation on surface localisation of P2X1
receptors. Vasa deferentia were exposed to agonist (100 WM K,L-
meATP) or no agonist for 30 min followed by incubation in 500
Wg/ml Sulfo-NHS-LC-Biotin for the time indicated (minutes) in the
continued presence of agonist A. Puri¢ed biotinylated P2X1 (inset
shows total P2X1). B: Optical density of the biotinylated P2X1 pro-
tein bands in A plotted against time in biotinylating agent (open
circles: no agonist, closed circles: agonist-stimulated). Size markers
are in kDa.
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incubation period, i.e. it incorporates a component of recep-
tors that may have been recycled to the surface. Therefore we
looked at the time-course of biotinylation to determine if any
changes in the level of surface P2X1 receptor following ago-
nist stimulation could be resolved. Biotinylation was very rap-
id; V80% of surface P2X1 receptors were labelled within the
¢rst 2 min (Fig. 3B, open symbols). There was some indica-
tion that the level of biotinylated P2X1 receptors was reduced
compared to control tissues following a 1 min incubation in
Sulfo-NHS-LC-Biotin. However, on longer incubation with
biotinylating agent the levels of surface expression were indis-
tinguishable between agonist-stimulated and control tissues,
as was the case in the initial studies. Thus, if vas deferens
P2X1 receptors are internalised during the presence of agonist,
there must be a continual shuttling of receptor back and forth
from the membrane surface in order to give equivalent levels
of biotinylation with non-agonist-stimulated cells. In order to
overcome such a masking e¡ect we reduced the biotinylating
agent to submaximal concentrations (V30%) in order to slow
the rate of the reaction and therefore reduced the probability
of labelling transient surface P2X1 receptors.
When the concentration of Sulfo-NHS-LC-Biotin was re-
duced to 50 Wg/ml (V30% maximum labelling), a clear de-
crease in P2X1 receptor biotinylation was observed in the
presence of agonist indicating internalisation of P2X1 recep-
tors (Fig. 4). This di¡erence was apparent after 5 min bio-
tinylation and by 10 min there was a 47.0 þ 12.3% decrease in
the amount of receptor biotinylation in agonist-stimulated
compared to control tissues (n = 4 experiments). When K,L-
meATP was washed o¡ prior to biotinylation the level of
P2X1 receptor expression recovered to 78.6 þ 4.9% of the con-
trol response (see closed triangle point in Fig. 4B) and showed
that the decrease in biotinylation was not due to the K,L-
meATP interfering with the ability of the Sulfo-NHS-LC-Bio-
tin to react with the cell surface receptors.
Contraction studies were used to compare the changes in
surface P2X1 receptor expression with recovery of functional
P2X receptors. The metabolically stable ATP analogue, K,L-
meATP (10 WM), evoked transient contractile responses of the
vas deferens that decayed during the continued presence of
agonist (Fig. 5A). Following 10 min washout of K,L-meATP
the response to a subsequent application of agonist evoked a
contraction that was V40% of the control response (in con-
trast to V80% recovery of surface expression). Full recovery
of contractile responses following agonist stimulation required
a 30 min post wash period (Fig. 5). There was no signi¢cant
di¡erence in percentage recovery between a 2 min application
Fig. 4. Agonist stimulation decreases surface localisation of the
P2X1 receptor. Vasa deferentia were exposed to agonist (100 WM
K,L-meATP) (b) or no agonist (a), for 30 min followed by incuba-
tion in 50 Wg/ml Sulfo-NHS-LC-Biotin for the time indicated (min-
utes). A: Puri¢ed biotinylated P2X1 (inset shows total P2X1).
B: Optical density of the biotinylated P2X1 protein bands in A
(and from three other duplicate experiments not shown) plotted
against time in biotinylating agent (b agonist-stimulated; a no ago-
nist). The closed triangle represents a single point (gels not shown)
for samples which had the agonist washed away immediately prior
to biotinylation. Points are plotted as % maximum value (optical
density for the band corresponding to 10 min biotinylation, no ago-
nist for that particular experiment) þ S.E.M. (n = 4 experiments, two
rats per experiment). Size markers are in kDa.
Fig. 5. Time dependent recovery of P2X1 receptor-mediated contrac-
tions. A: Representative traces of isometric tensions induced by a
2 min application of 10 WM K,L-meATP (p) recorded from rat vas
deferens in organ baths. Recovery times are given above the broken
lines. B: Mean peak values ( þ S.E.M.) as a percentage of initial re-
sponse (2 min application, 30 min recovery) for 2 min and 30 min
applications of agonist with either a 10 min or 30 min recovery
time. Note the recovery of the response after 10 min is independent
of the application time indicating that desensitisation of the receptor
(either internalisation of physical conformational changes) occurs
within the ¢rst 2 min of agonist exposure.
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(39 þ 6%, n = 13) and 30 min applications (44 þ 10%, n = 12)
(Fig. 5). The inability of the vas deferens to elicit a full re-
sponse after 10 min recovery is due to desensitisation of the
P2X receptors rather than an inability of the contractile ap-
paratus to respond since applications of the K-adrenoceptor
agonist arterenol (10 WM) given directly after the second ap-
plications of K,L-meATP elicit a full contractile response (data
not shown).
4. Discussion
In this study we have shown that agonist stimulation leads
to P2X1 receptor internalisation and receptor recycling. Using
the biotinylation technique it was estimated that s 50% of
P2X1 receptors were internalised during the continued pres-
ence of K,L-meATP (Fig. 4). This is the ¢rst time that inter-
nalisation of native P2X1 receptors has been reported. Under
physiological conditions it is likely that ATP released from
sympathetic nerves will similarly result in P2X1 receptor in-
ternalisation. The decrease in surface receptor labelling prob-
ably underestimates the true level of receptor internalisation
in response to agonist as it will also incorporate labelling of
recycled receptors. Our results are consistent with recent stud-
ies using over-expressed recombinant P2X1^GFP tagged re-
ceptors [10,11]. For P2X1^GFP chimeric receptors there was
a s 80% decrease in steady-state £uorescence following con-
tinued agonist stimulation associated with internalisation of
the chimera and quenching of the GFP signal by the acidic
environment in the endosomes. The use of the £uorescent
chimeric receptors gave a measure of the steady-state levels
of surface vs. internalised P2X1 receptors. Our results with a
saturating concentration of biotinylating agent (that gives a
measure of the number of receptors that have been expressed
at the surface during the incubation period) indicate that na-
tive smooth muscle P2X1 receptors once internalised are sub-
sequently quickly shuttled to and from the membrane. Work
on recycling of the transferin receptor has demonstrated the
existence of two compartments for internalised receptors: a
peripheral compartment from which rapid recycling is possi-
ble and a perinuclear compartment from which recycling is
slow [16,17]. Due to the apparent quick recycling rate of in-
ternalised P2X1 receptors indicated in this study, it is likely
that they are internalised to the rapid recycling peripheral
compartment as has been shown for the GABAA receptor
[18].
P2X1 receptor internalisation and shuttling can be added to
an existing model [19,20] of receptor desensitisation, to de-
scribe the activation, inactivation, internalisation and recovery
of P2X1 receptors (Fig. 6). Following agonist binding the
channel rapidly opens (in patch clamp studies the rate of
rise of P2X currents is as fast as the solution exchange [21]
and it is likely that the channel opens almost instantaneously
following ligand binding as has been shown for other ligand-
gated ion channels). The rapid mono-exponential decay of
native and recombinant P2X1 receptor currents (dV200^300
ms [22]) corresponds to a single step to a ligand bound in-
activated state [23]. From this state the receptor can subse-
quently be internalised (s 80% internalisation in 2^3 min)
[10]. The recovery of P2X1 receptors from desensitisation
therefore proceeds in two steps, (i) recycling of P2X1 receptors
to the surface of the cell followed by (ii) recovery from the
inactivated state. Internalisation of the P2X1 receptor is un-
likely to be the major determinant of the recovery of re-
sponses following agonist stimulation since 10 min after ago-
nist stimulation V80% (Fig. 4, closed triangle) of the
receptors had re-appeared on the cell surface, however, only
V40% of the contractile response was recovered (Fig. 5).
Therefore transitions into and out of the inactivated state
are most likely to be the rate-limiting step in desensitisation
and recovery. We have recently suggested that an intracellular
messenger and/or intact cytoskeleton contribute to P2X1 re-
ceptor recovery in vascular smooth muscle [23]. Whether it is
necessary for receptors to be internalised in order to recover
inactivation is unclear. A decrease in recycling of the P2X1
receptor to the surface would provide a mechanism for the
longer term down regulation of P2X receptor-mediated re-
sponses. Thus smooth muscle cells could regulate responsive-
ness to repeated ATP stimulation both in the short (receptor
inactivation) and long term (decreased surface expression).
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